Vremec David, Shortman Ken
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
Methods Mol Biol. 2008;415:163-78. doi: 10.1007/978-1-59745-570-1_10.
Dendritic cells (DC) are widely regarded as the most potent cellular inducers of the adaptive immune response; so, immunotherapy through DC manipulation is a promising option in the future fight against many human ailments. We have developed a method of isolating DC from the mouse that involves efficient extraction from tissues, followed by the selection of the lightest density cells, then depletion of non-DC through a cocktail of monoclonal antibodies and anti-immunoglobulin magnetic beads. Finally, purification and segregation into DC subtypes is achieved by immunofluorescent labeling and sorting. This has demonstrated a network of DC populations differing in surface phenotype and function. We can now produce larger numbers of many of these DC subpopulations from their precursors using bone marrow cultures supplemented with fms-like tyrosine kinase 3 ligand (Flt3L). The culture-generated DC can be aligned with the populations directly isolated from tissues. Combining the in vivo and in vitro systems will make study of murine DC and their alignment to their human counterparts an easier break process.
树突状细胞(DC)被广泛认为是适应性免疫反应中最有效的细胞诱导剂;因此,通过操控DC进行免疫治疗是未来对抗多种人类疾病的一个有前景的选择。我们已经开发出一种从小鼠体内分离DC的方法,该方法包括从组织中高效提取,接着选择密度最轻的细胞,然后通过单克隆抗体和抗免疫球蛋白磁珠混合物去除非DC细胞。最后,通过免疫荧光标记和分选实现DC亚型的纯化和分离。这揭示了一个在表面表型和功能上存在差异的DC群体网络。现在,我们可以使用添加了fms样酪氨酸激酶3配体(Flt3L)的骨髓培养物,从其前体中产生大量的这些DC亚群。培养产生的DC可以与直接从组织中分离的群体相对应。将体内和体外系统相结合将使对小鼠DC及其与人类对应物的对应关系的研究成为一个更容易突破的过程。